GSK plc (NYSE:GSK)

45.01
Delayed Data
As of May 24
 +0.255 / +0.57%
Today’s Change
37.80
Today|||52-Week Range
46.97
+2.05%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$113.2B

Company Description

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Pharmaceuticals; Pharmaceuticals R&D; Vaccines and Consumer Healthcare. The Pharmaceuticals segment focuses on developing medicines in respiratory and infectious diseases, oncology, and immuno-inflammation. The Pharmaceuticals R&D segment focuses on science related to the immune system, the use of human genetics and advanced technologies, and is driven by the multiplier effect of Science x Technology x Culture. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza, and bacterial meningitis. The Consumer Healthcare segment develops and markets brands in the oral health, pain relief, respiratory, nutrition and gastro intestinal, and skin health categories. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Contact Information

GSK Plc
980 Great West Road
Middlesex Greater London TW8 9GS
P:442080475000
Investor Relations:

Employees

Shareholders

Other institutional7.88%
Mutual fund holders5.38%
Individual stakeholders--

Top Executives

Emma N. WalmsleyChief Executive Officer & Executive Director
Iain James MackayChief Financial Officer & Executive Director
Jon EllisVP & Head-Technology Business Development
Tony WoodChief Scientific Officer-Designate
Hal V. BarronExecutive Director & Chief Scientific Officer